<PAPER><mode2 name='PMC4266572' hasDoc='yes' version='597'></mode2><article xmlns:mml='http://www.w3.org/1998/Math/MathML' xmlns:xlink='http://www.w3.org/1999/xlink' article-type='research-article'><front><journal-meta><journal-id journal-id-type='nlm-ta'>Alzheimers Res Ther</journal-id><journal-id journal-id-type='iso-abbrev'>Alzheimers Res Ther</journal-id><journal-title-group><journal-title>Alzheimer's Research &amp; Therapy</journal-title></journal-title-group><issn pub-type='epub'>1758-9193</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type='pmcid'>4266572</article-id><article-id pub-id-type='publisher-id'>76</article-id><article-id pub-id-type='doi'>10.1186/s13195-014-0076-z</article-id><article-categories><subj-group subj-group-type='heading'><subject>Research</subject></subj-group></article-categories><title-group><article-title><s sid='1'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1><CoreSc2 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc2>Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep Latency Test</s></article-title></title-group><contrib-group><contrib contrib-type='author' corresp='yes'><name><surname>Ferman</surname><given-names>Tanis J</given-names></name><address><email>ferman.tanis@mayo.edu</email></address><xref rid='Aff1' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Smith</surname><given-names>Glenn E</given-names></name><address><email>smitg@mayo.edu</email></address><xref rid='Aff2' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Dickson</surname><given-names>Dennis W</given-names></name><address><email>dickson.dennis@mayo.edu</email></address><xref rid='Aff3' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Graff-Radford</surname><given-names>Neill R</given-names></name><address><email>graffradford.neill@mayo.edu</email></address><xref rid='Aff4' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Lin</surname><given-names>Siong-Chi</given-names></name><address><email>lin.siongchi@mayo.edu</email></address><xref rid='Aff5' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Wszolek</surname><given-names>Zbigniew</given-names></name><address><email>wszolek.zbigniew@mayo.edu</email></address><xref rid='Aff4' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Van Gerpen</surname><given-names>Jay A</given-names></name><address><email>vangerpen.jay@mayo.edu</email></address><xref rid='Aff4' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Uitti</surname><given-names>Ryan</given-names></name><address><email>uitti@mayo.edu</email></address><xref rid='Aff4' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Knopman</surname><given-names>David S</given-names></name><address><email>knopman@mayo.edu</email></address><xref rid='Aff6' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Petersen</surname><given-names>Ronald C</given-names></name><address><email>peter8@mayo.edu</email></address><xref rid='Aff6' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Parisi</surname><given-names>Joseph E</given-names></name><address><email>parisi.joseph@mayo.edu</email></address><xref rid='Aff7' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Silber</surname><given-names>Michael H</given-names></name><address><email>msilber@mayo.edu</email></address><xref rid='Aff8' ref-type='aff'></xref></contrib><contrib contrib-type='author'><name><surname>Boeve</surname><given-names>Bradley F</given-names></name><address><email>bboeve@mayo.edu</email></address><xref rid='Aff6' ref-type='aff'></xref><xref rid='Aff8' ref-type='aff'></xref></contrib><aff id='Aff1'><label></label>Department of Psychiatry and Psychology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224 USA </aff><aff id='Aff2'><label></label>Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 USA </aff><aff id='Aff3'><label></label>Department of Pathology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224 USA </aff><aff id='Aff4'><label></label>Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224 USA </aff><aff id='Aff5'><label></label>Center for Sleep Medicine, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224 USA </aff><aff id='Aff6'><label></label>Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 USA </aff><aff id='Aff7'><label></label>Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 USA </aff><aff id='Aff8'><label></label>Center for Sleep Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 USA </aff></contrib-group><pub-date pub-type='epub'><day>10</day><month>12</month><year>2014</year></pub-date><pub-date pub-type='pmc-release'><day>10</day><month>12</month><year>2014</year></pub-date><pub-date pub-type='collection'><year>2014</year></pub-date><volume>6</volume><issue>9</issue><elocation-id>76</elocation-id><history><date date-type='received'><day>30</day><month>4</month><year>2014</year></date><date date-type='accepted'><day>14</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>© Ferman et al.; licensee BioMed Central Ltd. 2014</copyright-statement><license license-type='open-access'><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type='uri' xlink:href='http://creativecommons.org/licenses/by/4.0'>http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type='uri' xlink:href='http://creativecommons.org/publicdomain/zero/1.0/'>http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id='Abs1'><sec><title>Introduction</title><p><s sid='2'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Excessive daytime sleepiness is a commonly reported problem in dementia with Lewy bodies (DLB).</s><s sid='3'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1> We examined the relationship between nighttime sleep continuity and the propensity to fall asleep during the day in clinically probable DLB compared to Alzheimer’s disease (AD) dementia.</s></p></sec><sec><title>Methods</title><p><s sid='4'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1><CoreSc2 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc2>A full-night polysomnography was carried out in 61 participants with DLB and 26 with AD dementia.</s><s sid='5'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Among this group, 32 participants with DLB and 18 with AD dementia underwent a daytime Multiple Sleep Latency Test (MSLT).</s><s sid='6'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Neuropathologic examinations of 20 participants with DLB were carried out.</s></p></sec><sec><title>Results</title><p><s sid='7'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>Although nighttime sleep efficiency did not differentiate diagnostic groups, the mean MSLT initial sleep latency was significantly shorter in participants with DLB than in those with AD dementia (mean 6.4 ± 5 minutes vs 11 ± 5 minutes, <italic>P</italic> &lt;0.01).</s><s sid='8'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In the DLB group, 81% fell asleep within 10 minutes compared to 39% of the AD dementia group (<italic>P</italic> &lt;0.01), and 56% in the DLB group fell asleep within 5 minutes compared to 17% in the AD dementia group (<italic>P</italic> &lt;0.01).</s><s sid='9'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Daytime sleepiness in AD dementia was associated with greater dementia severity, but mean MSLT latency in DLB was not related to dementia severity, sleep efficiency the night before, or to visual hallucinations, fluctuations, parkinsonism or rapid eye movement sleep behavior disorder.</s><s sid='10'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> These data suggest that abnormal daytime sleepiness is a unique feature of DLB that does not depend on nighttime sleep fragmentation or the presence of the four cardinal DLB features.</s><s sid='11'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Of the 20 DLB participants who underwent autopsy, those with transitional Lewy body disease (brainstem and limbic) did not differ from those with added cortical pathology (diffuse Lewy body disease) in dementia severity, DLB core features or sleep variables.</s></p></sec><sec><title>Conclusions</title><p><s sid='12'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>Daytime sleepiness is more likely to occur in persons with DLB than in those with AD dementia.</s><s sid='13'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1><CoreSc2 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc2> Daytime sleepiness in DLB may be attributed to disrupted brainstem and limbic sleep–wake physiology, and further work is needed to better understand the underlying mechanisms.</s></p></sec></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type='introduction' id='Sec1'><title>Introduction</title><p><s sid='14'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Daytime somnolence is commonly reported in patients with dementia with Lewy bodies (DLB) [<xref rid='CR1' ref-type='bibr'>1</xref>–<xref rid='CR3' ref-type='bibr'>3</xref>], and it is a major stressor for caregivers [<xref rid='CR4' ref-type='bibr'>4</xref>].</s><s sid='15'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> When daytime sleepiness is subjectively and objectively found in AD dementia, it is typically related to greater dementia severity [<xref rid='CR5' ref-type='bibr'>5</xref>,<xref rid='CR6' ref-type='bibr'>6</xref>].</s><s sid='16'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In contrast, DLB daytime sleepiness based on informant report occurs early in the disease [<xref rid='CR2' ref-type='bibr'>2</xref>] and has been documented to occur in the Mild Cognitive Impairment stage of DLB [<xref rid='CR7' ref-type='bibr'>7</xref>].</s><s sid='17'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Using the Multiple Sleep Latency Test (MSLT), we sought to objectively confirm whether patients with DLB have a greater propensity to fall asleep in a permissive setting compared to patients with AD dementia.</s><s sid='18'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> If daytime sleepiness can be empirically confirmed in early DLB and distinguished from AD dementia, this has implications for the early clinical detection of DLB.</s></p><p><s sid='19'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>Since nighttime sleep debt is well known to increase the daytime drive to sleep in normal populations [<xref rid='CR8' ref-type='bibr'>8</xref>], we investigated whether sleep fragmentation or poor sleep efficiency the night before was associated with subjective and objective daytime sleepiness.</s><s sid='20'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Moreover, sleep fragmentation due to respiratory and movement-related arousals can occur in DLB and Parkinson’s disease [<xref rid='CR9' ref-type='bibr'>9</xref>–<xref rid='CR12' ref-type='bibr'>12</xref>], but it is not known if these nocturnal arousals are sufficient to interfere with daytime alertness.</s></p></sec><sec sec-type='materials|methods' id='Sec2'><title>Methods</title><sec id='Sec3'><title>Patients</title><p><s sid='21'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>Patients were consecutively recruited through the Neurology and Neuropsychology clinics at the Mayo Clinic and enrolled as part of the Mayo Clinic’s Alzheimer’s Disease Research Center (ADRC; Jacksonville, FL, and Rochester, MN, USA).</s><s sid='22'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> All patients had a reliable informant who provided a clinical history and completed symptom rating scales.</s><s sid='23'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The clinical diagnosis was determined by a consensus of neurologists and neuropsychologists.</s><s sid='24'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> Patients were asked to participate if criteria were met for clinically probable DLB requiring dementia plus at least two of four clinical features (visual hallucinations, fluctuations, parkinsonism and rapid eye movement (REM) sleep behavior disorder (RBD)) [<xref rid='CR13' ref-type='bibr'>13</xref>].</s><s sid='25'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Established diagnostic criteria for clinically probable AD dementia were used [<xref rid='CR14' ref-type='bibr'>14</xref>].</s><s sid='26'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The determination of the presence of dementia was based on formal neurocognitive assessment requiring at least two areas of cognitive impairment and informant report of impaired instrumental activities of daily living that represented a decline from premorbid levels [<xref rid='CR15' ref-type='bibr'>15</xref>].</s><s sid='27'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The terms <italic>dementia with Lewy bodies</italic> and <italic>Alzheimer’s disease dementia</italic> are used to represent clinically probable DLB and AD dementia, respectively.</s></p><p><s sid='28'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The study was approved by the Mayo Clinic Institutional Review Board, and informed consent for participation was obtained from every participant and a surrogate.</s></p></sec><sec id='Sec4'><title>Clinical characterization</title><p><s sid='29'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>We administered the Global Deterioration Scale (GLDS) [<xref rid='CR16' ref-type='bibr'>16</xref>] and the Folstein Mini Mental State Examination score [<xref rid='CR17' ref-type='bibr'>17</xref>] to represent general ratings of dementia severity.</s><s sid='30'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A history of the presence or absence of RBD was documented with the Mayo Sleep Questionnaire [<xref rid='CR18' ref-type='bibr'>18</xref>] and confirmed via informant interview.</s><s sid='31'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Each patient underwent a neurologic examination, which included the Unified Parkinson’s Disease Rating Scale for motor signs [<xref rid='CR19' ref-type='bibr'>19</xref>].</s><s sid='32'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Patients were considered to have parkinsonism if two of the four cardinal features were present (bradykinesia, rigidity, resting tremor and/or postural instability).</s><s sid='33'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Fluctuations were deemed present based on a score of 3 or 4 on the Mayo Fluctuations Scale [<xref rid='CR1' ref-type='bibr'>1</xref>].</s><s sid='34'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Informants completed a visual hallucinations questionnaire and were interviewed to obtain information about the presence, type and onset of visual hallucinations.</s><s sid='35'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The Epworth Sleepiness Scale (ESS) was administered to the informant, who was asked to rate the patient’s likelihood to fall sleep in eight situations [<xref rid='CR20' ref-type='bibr'>20</xref>].</s><s sid='36'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Measures of depression were obtained from self-report using the Geriatric Depression Scale–Short Form [<xref rid='CR21' ref-type='bibr'>21</xref>] and from informant report using the Neuropsychiatric Inventory Questionnaire–Short Form (NPI-Q) [<xref rid='CR22' ref-type='bibr'>22</xref>].</s></p></sec><sec id='Sec5'><title>Procedures</title><p><s sid='37'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>A full-night polysomnography was carried out with 61 patients with DLB and 26 patients with AD dementia.</s><s sid='38'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> The MSLT was undertaken with 32 DLB and 18 AD dementia, and there was no difference in demographics, dementia severity or core features from those who chose not to carry out the MSLT.</s></p><p><s sid='39'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The MSLT was comprised of four daytime nap times with 2 hours of wakefulness between each nap opportunity.</s><s sid='40'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Participants were asked to lie comfortably with lights out and were advised to try to fall asleep.</s><s sid='41'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Sleep onset was noted to occur when there were either three complete epochs of stage 1 sleep or any one epoch of unequivocal sleep.</s><s sid='42'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Once either sleep criterion was observed, the initial sleep latency was recorded, the subject was awakened and that nap session was terminated.</s><s sid='43'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> If there was no sleep onset within a 20-minute period, then the nap session was terminated.</s></p><p><s sid='44'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Scoring of sleep stages was carried out according to standard guidelines [<xref rid='CR23' ref-type='bibr'>23</xref>,<xref rid='CR24' ref-type='bibr'>24</xref>], and each polysomnogram was reviewed by a sleep medicine clinician certified by the American Board of Sleep Medicine.</s><s sid='45'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> All polysomnography studies involved continuous videotaping synchronized to standard monitoring using the following montage: two electro-oculogram derivations, three electroencephalography derivations f(Fz-Cz, Cz-Oz, C4-A1), an electrocardiogram, chin and at least two limb surface electromyographic electrodes, oronasal airflow, sonogram, oxyhemoglobin saturation, and chest and abdomen inductance plethysmography.</s></p><p><s sid='46'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1><italic>Sleep efficiency</italic> was defined as the total sleep time divided by the total time in bed multiplied by 100%.</s><s sid='47'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> An <italic>arousal</italic> was defined as an abrupt shift of electroencephalography frequency including alpha, theta or frequency higher than 16 Hz, but not sleep spindles, after at least 10 seconds of stable sleep that lasted at least 3 seconds during any sleep stage, but not long enough to be classified as awake.</s><s sid='48'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> An arousal during REM sleep was scored only if it was accompanied by increased amplitude of submental electromyography.</s><s sid='49'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> For an obstructive event, there was a 10-second or longer period with a clear amplitude decrease in breathing from baseline associated with over 3% oxygen desaturation or an arousal from the obstructive events.</s><s sid='50'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In a central event, there was a reduction or absence of breathing and respiratory effort that lasted 10 seconds or longer with associated reduced airflow.</s><s sid='51'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> For a hypopnea, there was a reduction of airflow and a reduction of thoracic and/or abnormal movement that led to an arousal.</s><s sid='52'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The respiratory disturbance index represents the sum of disordered breathing events related to obstructive apneas, central apneas, mixed apneas, hypopneas and respiratory effort–related changes averaged over the total sleep time, which represents a value of the sum per hour.</s><s sid='53'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A <italic>periodic limb movement</italic> was defined as periodic contraction of the lower legs, either unilateral or bilateral, with a series of four consecutive movements separated by 4 to 90 seconds, with each movement lasting between 0.5 and 5 seconds and not associated with respiratory events.</s><s sid='54'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The mean number of periodic limb movements per hour associated with arousals was considered the movement-related arousals per hour.</s><s sid='55'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A <italic>spontaneous arousal</italic> was defined as an arousal not related to disordered breathing or movements, and the spontaneous arousal per hour reflects the number of spontaneous arousals per hour averaged over total sleep time.</s><s sid='56'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The finding of REM sleep without atonia was considered present if muscle tone during REM sleep was unequivocally abnormally increased and if no epileptiform discharges were noted on the record.</s></p></sec><sec id='Sec6'><title>Neuropathological examination</title><p><s sid='57'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>Autopsy specimens were obtained for 20 patients with DLB and none of the patients with AD.</s><s sid='58'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Standardized neuropathologic assessments, including macroscopic and microscopic evaluations, were carried out with assignment of a pathologic diagnosis using established DLB criteria [<xref rid='CR13' ref-type='bibr'>13</xref>,<xref rid='CR25' ref-type='bibr'>25</xref>].</s><s sid='59'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Lewy body distribution was determined on the basis of Lewy body counts using a polyclonal antibody to α-synuclein, with diffuse Lewy body disease (DLBD), including those with Lewy-related pathology in the neocortex and limbic and brainstem regions, and transitional Lewy body disease (TLBD), including those with Lewy-related pathology in the limbic and brainstem regions.</s><s sid='60'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Braak neurofibrillary tangle (NFT) stage was identified using thioflavin-S microscopy or the Bielschowsky silver stain technique [<xref rid='CR26' ref-type='bibr'>26</xref>].</s></p></sec><sec id='Sec7'><title>Statistical analysis</title><p><s sid='61'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>For each patient group, sleep efficiency and mean MSLT initial sleep latency showed normal distributions using the Kolmogorov-Smirnov test.</s><s sid='62'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Equality of variance was confirmed using the Levene test of homogeneity of variance and Mauchly’s test of sphericity.</s><s sid='63'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Comparisons of continuous variables used the one-way analysis of variance, and comparisons of categorical variables used the Chi-square test.</s><s sid='64'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A repeated measures analysis of covariance was used to compare the four MSLT nap latencies between DLB and AD dementia with the GLDS (a measure of dementia severity) as the covariate.</s><s sid='65'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Two-tailed Pearson correlational analyses were carried out to examine the associations between continuous variables.</s><s sid='66'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In an effort to reduce type 1 error from multiple comparisons, the <italic>P</italic>-value for significance was set at ≤0.01.</s><s sid='67'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> To determine how nighttime sleep efficiency compared to community-dwelling older adults without an established dementia, individual <italic>z</italic>-scores were calculated based on data stratified by age and sex in a large community sample [<xref rid='CR27' ref-type='bibr'>27</xref>].</s></p></sec></sec><sec sec-type='results' id='Sec8'><title>Results</title><sec id='Sec9'><title>Clinical characterization</title><p><s sid='68'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>In the DLB group, 23% had two core DLB features, 41% had three core DLB features and 36% had four core DLB features.</s><s sid='69'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In the AD dementia group, eight participants had one of the core DLB features.</s><s sid='70'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Demographic and clinical variables were compared between groups (see Table <xref rid='Tab1' ref-type='table'>1</xref>).</s><s sid='71'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The patient groups did not differ in age, education, dementia severity or duration of cognitive impairment.</s><s sid='72'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Parkinsonism severity, based on UPDRS scores, was greater in DLB compared to AD dementia.</s><s sid='73'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Informants provided higher ratings on the Epworth Sleepiness Scale for DLB compared to AD dementia.</s><s sid='74'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The DLB group had higher self-reported depression scores compared to the AD dementia group, though there was no difference in informant report of depression between groups using the NPI-Q.</s><s sid='75'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There was no difference between DLB and AD dementia in the frequency of cholinesterase inhibitor use (DLB 73% vs AD dementia 62%, <italic>X</italic><sup>2</sup> = 1.2, p =0.27).</s><s sid='76'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Of the DLB group, 36% were taking carbidopa-levodopa.</s><s sid='77'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Of the four DLB patients prescribed pramipexole or ropinirole, two were also taking carbidopa-levodopa.</s><s sid='78'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In the AD dementia group, 7% were taking carbidopa-levodopa.</s><s sid='79'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> None of the patients were taking amantadine, anticholinergic agents, or benzodiazepines at the time of the sleep study.</s><s sid='80'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There was no difference in demographics, dementia severity, number or duration of core DLB features between patients who participated in the MSLT compared to those who opted out.</s><table-wrap id='Tab1'><label>Table 1</label><caption><p><bold>Demographic and clinical variables</bold><sup><bold>a</bold></sup></p></caption><table rules='groups' frame='hsides'><thead><tr><th><bold>Variables</bold></th><th><bold>DLB</bold></th><th><bold>AD dementia</bold></th><th><bold><italic>F</italic></bold><bold>/</bold><bold><italic>χ</italic></bold><sup><bold>2</bold></sup></th><th><bold><italic>P</italic></bold><bold>-value</bold></th></tr></thead><tbody><tr><td>No. of participants</td><td align='center'>61</td><td align='center'>26</td><td align='center'></td><td align='center'></td></tr><tr valign='top'><td>Males, %</td><td align='center'>84%</td><td align='center'>62%</td><td align='center'>5.0</td><td align='center'>0.03</td></tr><tr valign='top'><td>Age, yr</td><td align='center'>70.5 ± 7</td><td align='center'>70.8 ± 8</td><td align='center'>0.04</td><td align='center'>0.84</td></tr><tr valign='top'><td>Education, yr</td><td align='center'>14.6 ± 3</td><td align='center'>14.8 ± 3</td><td align='center'>0.12</td><td align='center'>0.73</td></tr><tr valign='top'><td>Estimated duration of cognitive impairment, yr</td><td align='center'>3.6 ± 2</td><td align='center'>4.6 ± 4</td><td align='center'>2.4</td><td align='center'>0.12</td></tr><tr valign='top'><td>Mini Mental State Examination score</td><td align='center'>23.4 ± 5</td><td align='center'>23.4 ± 4</td><td align='center'>0.004</td><td align='center'>0.95</td></tr><tr valign='top'><td>Global Deterioration Scale score</td><td align='center'>3.9 ± 1</td><td align='center'>3.7 ± 1</td><td align='center'>0.44</td><td align='center'>0.51</td></tr><tr valign='top'><td>Visual hallucinations, %</td><td align='center'>59%</td><td align='center'>8%</td><td align='center'>19.5</td><td align='center'>&lt;0.01</td></tr><tr valign='top'><td>Estimated duration of visual hallucinations, yr</td><td align='center'>2.1 ± 2</td><td align='center'>2.0 ± 1</td><td align='center'>0.008</td><td align='center'>0.93</td></tr><tr valign='top'><td>Parkinsonism, %</td><td align='center'>84%</td><td align='center'>0%</td><td align='center'>–</td><td align='center'>–</td></tr><tr valign='top'><td>Estimated duration of parkinsonism, yr</td><td align='center'>2.7 ± 3</td><td align='center'>–</td><td align='center'>–</td><td align='center'>–</td></tr><tr valign='top'><td>Unified Parkinson’s Disease Rating Scale score</td><td align='center'>10.4 + 8</td><td align='center'>0.35 + 1</td><td align='center'>29.0</td><td align='center'>&lt;0.01</td></tr><tr valign='top'><td>Probable RBD, %</td><td align='center'>90%</td><td align='center'>3.8%</td><td align='center'>–</td><td align='center'>–</td></tr><tr valign='top'><td>Estimated duration of RBD, yr</td><td align='center'>10.2 ± 11</td><td align='center'>2</td><td align='center'>–</td><td align='center'>–</td></tr><tr valign='top'><td>Mayo Fluctuations Scale score &gt;2, %</td><td align='center'>81%</td><td align='center'>21%</td><td align='center'>26.7</td><td align='center'>&lt;0.01</td></tr><tr valign='top'><td>Epworth Sleepiness Scale, informant</td><td align='center'>13.0 ± 6</td><td align='center'>8.3 ± 5</td><td align='center'>11.4</td><td align='center'>&lt;0.01</td></tr><tr valign='top'><td>Geriatric Depression Scale Score</td><td align='center'>4.6 ± 3.8</td><td align='center'>2.0 ± 1.5</td><td align='center'>9.3</td><td align='center'>&lt;0.01</td></tr><tr valign='top'><td>NPI-Q depression, informant report, %</td><td align='center'>36%</td><td align='center'>30%</td><td align='center'>0.19</td><td align='center'>0.66</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Values represent mean ± standard deviation, except where indicated otherwise. AD dementia, Alzheimer’s disease dementia; DLB, Dementia with Lewy bodies; NPI-Q, Neuropsychiatric Inventory Questionnaire–Short Form; RBD, Rapid eye movement sleep behavior disorder. We used Fisher’s exact test in χ<sup>2</sup> comparisons with less than five per cell, and no statistical comparisons were made with one or less per cell.</p></table-wrap-foot></table-wrap></p></sec><sec id='Sec10'><title>Full-night polysomnography</title><p><s sid='81'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Overnight polysomnography data are presented in Table <xref rid='Tab2' ref-type='table'>2</xref>.</s><s sid='82'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There was no difference in total sleep time, sleep efficiency or arousals during sleep between the DLB and AD dementia groups.</s><s sid='83'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There was also no difference in the number or types of arousals per hour or in the percentage of sleep time affected by arousals between groups.</s><s sid='84'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Arousals from periodic limb movements did not distinguish groups and were relatively infrequent, with a movement-related arousal index ≥15 in 8% of the DLB group and in 15% of the AD group (<italic>χ</italic><sup>2</sup> = 0.95, <italic>P</italic> =0.44).</s><s sid='85'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Breathing-related arousals with a respiratory disturbance index ≥15 were found 18% of the DLB group and 15% of the AD dementia group and did not differentiate groups (<italic>χ</italic><sup>2</sup> = 0.11, <italic>P</italic> =0.74).</s><table-wrap id='Tab2'><label>Table 2</label><caption><p><bold>Overnight polysomnography in the dementia with Lewy bodies and Alzheimer’s disease dementia groups</bold><sup><bold>a</bold></sup></p></caption><table rules='groups' frame='hsides'><thead><tr><th></th><th><bold>DLB</bold></th><th><bold>AD dementia</bold></th><th><bold><italic>F</italic></bold><bold>/</bold><bold><italic>χ</italic></bold><sup><bold>2</bold></sup></th><th><bold><italic>P</italic></bold><bold>-value</bold></th></tr></thead><tbody><tr><td>No. of participants</td><td align='center'>61</td><td align='center'>26</td><td align='center'></td><td align='center'></td></tr><tr valign='top'><td>Time in bed, min</td><td align='center'>488 ± 78</td><td align='center'>560 ± 65</td><td align='center'>17</td><td align='center'>&lt;0.01</td></tr><tr valign='top'><td>Total sleep time, min</td><td align='center'>348 ± 99</td><td align='center'>382 ± 77</td><td align='center'>2.43</td><td align='center'>0.12</td></tr><tr valign='top'><td>Sleep efficiency, %</td><td align='center'>72 ± 18</td><td align='center'>69 ± 17</td><td align='center'>0.24</td><td align='center'>0.63</td></tr><tr valign='top'><td>Initial sleep latency, min</td><td align='center'>27 ± 38</td><td align='center'>23 ± 20</td><td align='center'>0.26</td><td align='center'>0.61</td></tr><tr valign='top'><td>Initial REM sleep latency, min</td><td align='center'>144 ± 101</td><td align='center'>140 ± 105</td><td align='center'>0.03</td><td align='center'>0.87</td></tr><tr valign='top'><td>Stage N1, % total sleep time</td><td align='center'>12 ± 11</td><td align='center'>16 ± 12</td><td align='center'>1.9</td><td align='center'>0.17</td></tr><tr valign='top'><td>Stage N2, % total sleep time</td><td align='center'>53 ± 16</td><td align='center'>53 ± 13</td><td align='center'>0.005</td><td align='center'>0.99</td></tr><tr valign='top'><td>Stage N3, % total sleep time</td><td align='center'>22 ± 16</td><td align='center'>14 ± 9</td><td align='center'>5.6</td><td align='center'>0.02</td></tr><tr valign='top'><td>Stage REM, % total sleep time</td><td align='center'>14 ± 12</td><td align='center'>17 ± 8</td><td align='center'>1.7</td><td align='center'>0.19</td></tr><tr valign='top'><td>Arousal index/hr</td><td align='center'>25 ± 15</td><td align='center'>29 ± 17</td><td align='center'>0.88</td><td align='center'>0.35</td></tr><tr valign='top'><td>Respiratory disturbance index/hr</td><td align='center'>10 ± 11</td><td align='center'>8 ± 12</td><td align='center'>0.55</td><td align='center'>0.46</td></tr><tr valign='top'><td>Respiratory disturbance index ≥15, %</td><td align='center'>18%</td><td align='center'>15%</td><td align='center'>0.11</td><td align='center'>0.74</td></tr><tr valign='top'><td>Movement-related arousals/hr</td><td align='center'>4.3 ± 7</td><td align='center'>5.8 ± 6</td><td align='center'>1.28</td><td align='center'>0.28</td></tr><tr valign='top'><td>Spontaneous arousals/hr</td><td align='center'>8.7 ± 8</td><td align='center'>9.8 ± 8</td><td align='center'>0.32</td><td align='center'>0.57</td></tr><tr valign='top'><td>Oxygen saturation, %</td><td align='center'>94 ± 2</td><td align='center'>95 ± 2</td><td align='center'>0.52</td><td align='center'>0.47</td></tr><tr valign='top'><td>REM sleep without atonia, %</td><td align='center'>71%</td><td align='center'>8%</td><td align='center'>43.4</td><td align='center'>&lt;0.01</td></tr><tr valign='top'><td>Absence of REM sleep, %</td><td align='center'>19%</td><td align='center'>0%</td><td align='center'>–</td><td align='center'>–</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Values represent mean ± standard deviation or percentage per group. Index values/hour reflect the number of arousals per total hours of sleep time. AD dementia, Alzheimer’s disease dementia; DLB, Dementia with Lewy bodies; REM, Rapid eye movement. We used Fisher’s exact test <italic>for χ</italic><sup>2</sup> comparisons with less than five per cell, and no statistical comparisons were made with one or less per cell.</p></table-wrap-foot></table-wrap></p><p><s sid='86'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>In the DLB group, there was no relationship between nighttime sleep efficiency and age, dementia severity, sex, fluctuations, parkinsonism severity, depression indices or the presence or duration of visual hallucinations, RBD or parkinsonism.</s><s sid='87'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> When compared to age- and sex-stratified normative data for older adults [<xref rid='CR27' ref-type='bibr'>27</xref>], mean nighttime sleep efficiency was average for the DLB group (mean <italic>z</italic>-score = −0.6 ± 1.7) and low average for the AD dementia group (mean <italic>z</italic>-score = −1.1 ± 1.6).</s><s sid='88'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In DLB, poor sleep efficiency was associated with longer nighttime initial sleep latency (<italic>r</italic> = −0.41, <italic>P</italic> &lt;0.01), more time in N1 (r = −0.52, <italic>P</italic> &lt;0.01), a greater arousal index (<italic>R</italic> = −0.33, <italic>P</italic> =0.01) and more spontaneous arousals (<italic>r</italic> = −0.37, <italic>P</italic> &lt;0.01).</s><s sid='89'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Poor sleep efficiency in DLB was not associated with informant report of daytime sleepiness based on the Epworth Sleepiness Scale.</s></p><p><s sid='90'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>In the AD dementia group, there was no relationship between nighttime sleep efficiency and age, sex, dementia severity, fluctuations, parkinsonism severity or depression indices.</s><s sid='91'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Poor sleep efficiency was associated with more time in N1 (<italic>r</italic> = −0.65, <italic>P</italic> &lt;0.01) and a greater arousal index (<italic>r</italic> = −0.60, <italic>P</italic> &lt;0.01).</s><s sid='92'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Poor sleep efficiency in AD dementia showed a nonsignificant trend with informant report of daytime sleepiness based on the Epworth Sleepiness Scale (<italic>r</italic> = −0.43, <italic>P</italic> &lt;0.04).</s></p><p><s sid='93'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>Use of a cholinesterase inhibitor was not associated with differences in clinical, demographic or sleep variables between the diagnostic groups.</s><s sid='94'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Patients with DLB who were taking carbidopa-levodopa had greater parkinsonism severity compared to those not taking this agent (mean UPDRS =15 ± 7 vs 8 ± 7, <italic>F</italic> =13, <italic>P</italic> &lt;0.01), but they also had a lower arousal index (mean arousal index =19 ± 11 vs 29 ± 17, <italic>F</italic> =6.2, <italic>P</italic> =0.01) and fewer spontaneous arousals (mean spontaneous arousal/hour =5 ± 5 vs 11 ± 9, <italic>F</italic> =8.3, <italic>P</italic> &lt;0.01), suggesting a sleep benefit associated with such treatment.</s><s sid='95'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> This effect did not change when the few patients taking dopamine agonists were included in the comparison.</s></p><p><s sid='96'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>A clinical history of RBD was present in 90% of the DLB group.</s><s sid='97'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> REM sleep without atonia was confirmed in 71%, but REM sleep was not achieved in 19%, rendering it impossible to formally confirm RBD for them.</s><s sid='98'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> In this group with a clinical history of RBD, the patients who did not achieve REM sleep had significantly less total sleep time (no REM sleep =265 ± 99 minutes vs REM sleep without atonia =370 ± 91 minutes, <italic>F</italic> =11.2, <italic>P</italic> &lt;0.01) and lower sleep efficiency (no REM sleep =58% ±19 vs REM sleep without atonia =75% ± 16, <italic>F</italic> =12.3, <italic>P</italic> &lt;0.01) than their counterparts who achieved REM sleep.</s><s sid='99'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> REM sleep without atonia was found in two patients with AD dementia, despite the absence of a clinical history of dream enactment behavior during sleep.</s></p></sec><sec id='Sec11'><title>Multiple Sleep Latency Test</title><p><s sid='100'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Patients with DLB were more likely than those with AD dementia to have an abnormal mean MSLT initial sleep latency &lt;10 minutes (DLB =81% vs AD dementia =39%, <italic>χ</italic><sup>2</sup> = 9.2, <italic>P</italic> &lt;0.01) and &lt;5 minutes (DLB =56% vs AD dementia =17%, <italic>χ</italic><sup>2</sup> = 7.4, <italic>P</italic> =0.01).</s><s sid='101'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The mean MSLT initial sleep latency was shorter for DLB than AD dementia (DLB =6.4 ± 5 minutes vs AD dementia =11.3 ± 5 minutes, <italic>F</italic> =12.6, <italic>P</italic> &lt;0.01).</s><s sid='102'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Since dementia severity was associated with shorter mean MSLT initial sleep latencies in the AD dementia group (<italic>r</italic> = −0.59, <italic>P</italic> &lt;0.01), we also carried out a repeated measures analysis of covariance with GLDS as the covariate.</s><s sid='103'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The results showed a significant between-subjects effect, confirming shorter MSLT mean initial sleep latencies across the four naps for the DLB group compared to the AD dementia group (<italic>F</italic> =14.5, <italic>P</italic> &lt;0.001).</s><s sid='104'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There were no within-subjects effects, indicating no differences in mean initial sleep latencies between each of the four nap opportunities for either dementia group (see Figure <xref rid='Fig1' ref-type='fig'>1</xref>).<fig id='Fig1'><label>Figure 1</label><caption><p><bold>Multiple Sleep Latency Test mean initial sleep latency in dementia with Lewy bodies and Alzheimer’s disease dementia groups.</bold> AD, Alzheimer’s disease; DLB, Dementia with Lewy bodies.</p></caption><graphic id='MO1' xlink:href='13195_2014_76_Fig1_HTML'></graphic></fig></s></p><p><s sid='105'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>In DLB, mean MSLT initial sleep latency was not associated with age, dementia severity, sex or use of antiparkinsonian agents or cholinesterase inhibitors.</s><s sid='106'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There was also no relationship with clinical variables, such as the number of core DLB features, parkinsonism severity or duration of visual hallucinations, parkinsonism or RBD.</s><s sid='107'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Informant ratings of fluctuations and Epworth Sleepiness Scale items were correlated in the DLB group (<italic>r</italic> =0.45, <italic>P</italic> &lt;0.01) and in the AD dementia group (<italic>r</italic> =0.62, <italic>P</italic> &lt;0.01), but these data did not reach statistical significance when compared with mean MSLT initial sleep latency.</s><s sid='108'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> In DLB, nighttime sleep efficiency and arousal index were unrelated to mean MSLT initial sleep latency (<italic>r</italic> = −0.05, <italic>P</italic> =0.78), indicating that daytime sleepiness occurred regardless of the degree of nighttime sleep fragmentation.</s><s sid='109'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> When the sample was limited to include only the very mild and mild stage of dementia, the differences between the DLB and AD dementia groups in informant Epworth Sleepiness Scale scores and mean MSLT initial sleep latencies were upheld.</s><s sid='110'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> In the AD dementia group, there was a trend in the relationship between nighttime sleep efficiency and mean MSLT initial sleep latency (<italic>r</italic> = −0.49, <italic>P</italic> &lt;0.04) with a subset who had trouble sleeping at night who were also less likely to sleep during the day.</s><s sid='111'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> This type of low sleepability and hyperarousability is well documented in primary insomnia [<xref rid='CR28' ref-type='bibr'>28</xref>,<xref rid='CR29' ref-type='bibr'>29</xref>], but our study did not have sufficient statistical power for us to examine this relationship further in our AD dementia cohort.</s></p></sec><sec id='Sec12'><title>Neuropathologic characterization</title><p><s sid='112'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>In the DLB group, 20 patients came to autopsy an average of 4.1 ± 2 years following the formal sleep study.</s><s sid='113'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> All had neuropathologic confirmation of intermediate or high likelihood DLB.</s><s sid='114'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Among these patients, eight had TLBD with predominantly brainstem/subcortical Lewy-related pathology and twelve had DLBD with additional cortical Lewy-related pathology.</s><s sid='115'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In the TLBD group, five had a Braak NFT stage less than IV and three had a Braak NFT stage of IV.</s><s sid='116'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> In the DLBD group, two had a Braak NFT stage less than IV, seven had a Braak NFT stage of IV and three had a Braak NFT stage greater than IV.</s></p><p><s sid='117'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Braak NFT stage, Lewy distribution (TLBD vs DLBD) and intermediate vs high likelihood DLB were not associated with demographic, clinical, sleep or dementia severity indices.</s><s sid='118'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> As such, widespread cortical pathology does not appear to be a requirement for the dementia or other clinical or sleep features of DLB, including subjective or objective daytime sleepiness.</s></p></sec></sec><sec sec-type='discussion' id='Sec13'><title>Discussion</title><p><s sid='119'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>Patients with DLB exhibited greater daytime somnolence than those with AD dementia of similar age, sex and dementia severity.</s><s sid='120'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> On the MSLT, 81% of the DLB group fell asleep within a mean of 10 minutes in four daytime nap opportunities, compared to 39% of the AD group.</s><s sid='121'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Pathologic sleepiness, based on a mean MSLT initial sleep latency of less than 5 minutes, was evident in 56% of the DLB group compared to 17% of the AD dementia group.</s><s sid='122'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> This was consistent with subjective informant ratings of a higher Epworth Sleepiness Scale score in DLB compared to AD dementia from the larger sample.</s><s sid='123'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Although daytime somnolence was associated with dementia severity in AD dementia, this was not the case in DLB.</s><s sid='124'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> These data empirically confirm that daytime sleepiness is more likely to occur in patients with DLB than in those with AD dementia.</s></p><p><s sid='125'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>In DLB, the increased propensity to fall asleep during the day was not related to poor sleep quality the night before.</s><s sid='126'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Mean nighttime sleep efficiency was average when individual scores were compared to published age- and sex-stratified norms [<xref rid='CR27' ref-type='bibr'>27</xref>].</s><s sid='127'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Moreover, nighttime sleep efficiency in the DLB group was not associated with daytime sleepiness based on either objective measurement or informant ratings.</s><s sid='128'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1> Nonetheless, since poor sleep efficiency in the DLB group was associated with a higher number of spontaneous arousals, we examined whether extrapyramidal features, such as motor stiffness, which can disrupt sleep by restricting one’s ability to turn over [<xref rid='CR30' ref-type='bibr'>30</xref>], might have contributed to the daytime somnolence in our DLB group.</s><s sid='129'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> This has particular relevance, because daytime sleepiness is often seen in persons with Parkinson’s disease [<xref rid='CR31' ref-type='bibr'>31</xref>–<xref rid='CR36' ref-type='bibr'>36</xref>].</s><s sid='130'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> In our sample, the patients with DLB who had more severe motor problems actually had fewer spontaneous arousals, a sleep benefit related to their use of carbidopa-levodopa.</s><s sid='131'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> In addition, parkinsonism severity or use of carbidopa-levodopa was not associated with objective and subjective measures of daytime sleepiness.</s><s sid='132'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Therefore, neither parkinsonism severity nor carbidopa-levodopa appears to be primarily responsible for the daytime somnolence in our DLB sample.</s></p><p><s sid='133'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Sleep disorders, such as moderate to severe sleep apnea and periodic limb movement-related arousals, occurred in less than 20% of the entire sample, which is consistent with rates expected in normal community-dwelling older adults [<xref rid='CR37' ref-type='bibr'>37</xref>–<xref rid='CR39' ref-type='bibr'>39</xref>].</s><s sid='134'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Although 81% of the DLB group had a mean MSLT initial sleep latency shorter than 10 minutes, nighttime arousals related to respiration or movement were not associated with mean MSLT initial sleep latency or with informant ratings of the Epworth Sleepiness Scale of the larger sample.</s><s sid='135'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Thus, the presence of these sleep disorders did not account for disturbed arousal in our DLB group.</s></p><p><s sid='136'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>In our DLB cohort, objective and subjective assessment of an individual’s susceptibility to fall asleep during the day did not depend on the presence or duration of visual hallucinations, parkinsonism or RBD.</s><s sid='137'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Although the informant ratings of DLB fluctuations and sleepiness were interrelated, they were not perfectly correlated, and the correlation between DLB fluctuations and mean MSLT initial sleep latency did not reach significance.</s><s sid='138'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> This suggests that despite some overlap between DLB fluctuations and sleepiness, they are distinct entities.</s><s sid='139'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> A similar relationship has been observed in delirium, where altered consciousness is an important contributor but other signs must be present for a diagnosis of delirium to be made [<xref rid='CR40' ref-type='bibr'>40</xref>,<xref rid='CR41' ref-type='bibr'>41</xref>].</s><s sid='140'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Likewise, although disturbed arousal is a consistent element of DLB fluctuations [<xref rid='CR1' ref-type='bibr'>1</xref>,<xref rid='CR42' ref-type='bibr'>42</xref>], the added presence of other components, such as inconsistent abilities, episodes of incoherent speech or variable attention, are needed to constitute the waxing and waning state that characterize DLB fluctuations [<xref rid='CR1' ref-type='bibr'>1</xref>,<xref rid='CR42' ref-type='bibr'>42</xref>–<xref rid='CR45' ref-type='bibr'>45</xref>].</s><s sid='141'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Taken together, our data provide evidence that daytime sleepiness is a distinct feature of DLB that is not contingent on disease stage or on any one of the four core features of DLB.</s><s sid='142'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Further work is needed to determine if its presence helps improve diagnostic validity and reliable early detection of DLB.</s></p><p><s sid='143'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Of the 20 patients with DLB who underwent pathologic examination, all had confirmation of Lewy body disease.</s><s sid='144'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There was no difference in demographics, clinical or sleep variables between the eight patients with TLBD (which includes brainstem and limbic Lewy pathology) and the twelve with DLBD (includes added cortical pathology).</s><s sid='145'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Similarly, there was no difference between those with intermediate likelihood DLB and high likelihood DLB, which also takes into account concomitant neurofibrillary tangle pathology.</s><s sid='146'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> As such, neuronal loss and Lewy pathology in brainstem and limbic regions, without widespread cortical involvement, are sufficient to produce daytime sleepiness, dementia and the other core DLB features.</s><s sid='147'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> This is consistent with the Braak staging model of Lewy body disease, which suggests earlier involvement of brainstem and limbic regions relative to cortical regions [<xref rid='CR46' ref-type='bibr'>46</xref>].</s></p><p><s sid='148'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>We postulate that the mechanism underlying daytime sleepiness in DLB may be related to neuronal loss from the disease itself and triggered by the disruption of the brain regions responsible for sleep–wake physiology.</s><s sid='149'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In Lewy body disease, cell clusters that are particularly vulnerable include the locus coeruleus, the raphe nucleus, the tuberomammillary nucleus of the hypothalamus, the periaqueductal gray and the basal forebrain [<xref rid='CR25' ref-type='bibr'>25</xref>,<xref rid='CR47' ref-type='bibr'>47</xref>].</s><s sid='150'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> These nuclei constitute a neuronal network composed of multiple neurotransmitters known to regulate wakefulness that are referred to collectively as the ascending reticular activating system (ARAS) [<xref rid='CR48' ref-type='bibr'>48</xref>–<xref rid='CR52' ref-type='bibr'>52</xref>].</s><s sid='151'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Saper and colleagues [<xref rid='CR53' ref-type='bibr'>53</xref>] have proposed a sleep–wake switch model based on the reciprocal relationship between the wakefulness neurons of the ARAS and the sleep neurons of the ventrolateral preoptic hypothalamus (VLPO) [<xref rid='CR53' ref-type='bibr'>53</xref>], with the hypocretin cells of the lateral hypothalamus serving as a modulator of sleep–wake transitions [<xref rid='CR54' ref-type='bibr'>54</xref>,<xref rid='CR55' ref-type='bibr'>55</xref>].</s><s sid='152'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Further work is needed to determine whether our finding of essentially normal nighttime sleep efficiency in DLB, but greater daytime sleepiness, may reflect a bias or imbalance between the VLPO and ARAS, and whether there is an inequity in their modulation by the lateral hypothalamic hypocretin neurons.</s><s sid='153'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Although cerebrospinal fluid levels of hypocretin in DLB and Parkinson’s disease dementia show wide variability, ranging from very low to normal levels [<xref rid='CR56' ref-type='bibr'>56</xref>–<xref rid='CR58' ref-type='bibr'>58</xref>], there is pathologic evidence of greater hypocretin immunoreactive cell loss in DLB compared to AD [<xref rid='CR59' ref-type='bibr'>59</xref>,<xref rid='CR60' ref-type='bibr'>60</xref>], with one DLB study showing hypocretin cell loss correlating with hypersomnolence and α-synuclein [<xref rid='CR60' ref-type='bibr'>60</xref>].</s><s sid='154'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Whether hypocretin cell loss is directly related to Lewy-related pathology or is a consequence of lost input due to damage to the ARAS neuronal network in Lewy body disease is not yet known.</s><s sid='155'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> More detailed investigation of how the particular pathways known to be involved in sleep and wakefulness are affected in DLB is clearly needed.</s></p><p><s sid='156'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>A clinical history of RBD was present in 90% of our DLB sample, but it could be confirmed in only the 71% who actually achieved REM sleep during polysomnography.</s><s sid='157'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Of the 19% with DLB and a history of RBD who did not achieve REM sleep, these patients had less total sleep time and lower nighttime sleep efficiency than their counterparts who did achieve REM sleep.</s><s sid='158'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Those with a longer documented clinical duration of RBD also spent less time in REM sleep, which may explain why RBD eventually becomes quiescent in patients with very long histories of RBD [<xref rid='CR61' ref-type='bibr'>61</xref>].</s></p><p><s sid='159'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Some limitations to the study deserve mention.</s><s sid='160'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Replication with a larger sample size and with complete congruence between those who have undergone overnight polysomnography and daytime MSLT is needed.</s><s sid='161'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In addition, interpretation of the neuropathologic analysis is limited by the absence of AD autopsies and by the small number of DLB cases with sleep evaluations who have come to autopsy to date.</s><s sid='162'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In our effort to determine whether nighttime sleep efficiency was normal for age and sex, we calculated individual <italic>z</italic>-scores using a large normative data set that incorporated in-home overnight polysomnography.</s><s sid='163'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Although this setting may not be exactly comparable to the sleep laboratory, studies indicate good validity with in-home polysomnography, and discrepancies tend to be in the direction of better sleep efficiency at home relative to the sleep laboratory [<xref rid='CR62' ref-type='bibr'>62</xref>,<xref rid='CR63' ref-type='bibr'>63</xref>].</s><s sid='164'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Under these conditions, we deemed it reasonable to provide this comparison, recognizing that our laboratory findings of average sleep efficiency in the DLB group and low average sleep efficiency in the AD group may reflect an underestimate of true sleep efficiency for these groups.</s></p><p><s sid='165'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>In this study, we incorporated the MSLT, which is considered the gold standard for the objective measurement of sleepiness and relies on the assessment of how quickly one falls asleep when asked to do so.</s><s sid='166'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Further study is needed to investigate whether patients with DLB also have trouble maintaining wakefulness when asked to do so.</s></p></sec><sec sec-type='conclusion' id='Sec14'><title>Conclusions</title><p><s sid='167'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>This study provides objective confirmation, based on polysomnography data, that excessive daytime sleepiness is more likely to occur in patients with DLB than in those with AD dementia and that it is not attributable to poor sleep the night before.</s><s sid='168'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Moreover, daytime sleepiness in patients with DLB occurs in the early stages of the disease, whereas it tends to be associated with greater dementia severity in patients with AD dementia.</s><s sid='169'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> These data provide evidence that daytime sleepiness can be distinguished from the other core DLB features, including fluctuations.</s><s sid='170'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> If daytime sleepiness is a unique clinical feature of DLB, this has implications for improved early detection and differential diagnosis of DLB, for consideration of alternate treatment interventions, and for promoting our understanding of the pathologic and neuroanatomic involvement in DLB.</s></p></sec><sec id='Sec15'><title>Note</title><p>This article is part of a series on Lewy Body Dementia, edited by Ian McKeith and James Galvin. Other articles in this series can be found at <ext-link ext-link-type='uri' xlink:href='http://alzres.com/series/LewyBodyDementia'>http://alzres.com/series/LewyBodyDementia</ext-link></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-list><def-item><term>AD</term><def><p>Alzheimer’s disease</p></def></def-item><def-item><term>ARAS</term><def><p>Ascending reticular activating system</p></def></def-item><def-item><term>DLBs</term><def><p>Dementia with Lewy bodies</p></def></def-item><def-item><term>DLBD</term><def><p>Diffuse Lewy body disease</p></def></def-item><def-item><term>ESS</term><def><p>Epworth Sleepiness Scale</p></def></def-item><def-item><term>GLDS</term><def><p>Global Deterioration Scale</p></def></def-item><def-item><term>MMSE</term><def><p>Mini Mental State Examination</p></def></def-item><def-item><term>MSLT</term><def><p>Multiple Sleep Latency Test</p></def></def-item><def-item><term>NFT</term><def><p>Neurofibrillary tangle</p></def></def-item><def-item><term>NPI-Q</term><def><p>Neuropsychiatric Inventory Questionnaire–Short Form</p></def></def-item><def-item><term>RBD</term><def><p>Rapid eye movement sleep behavior disorder</p></def></def-item><def-item><term>RDI</term><def><p>Respiratory disturbance index</p></def></def-item><def-item><term>REM</term><def><p>Rapid eye movement</p></def></def-item><def-item><term>TLBD</term><def><p>Transitional Lewy body disease</p></def></def-item><def-item><term>UPDRS</term><def><p>Unified Parkinson’s Disease Rating Scale</p></def></def-item><def-item><term>VLPO</term><def><p>Ventrolateral preoptic hypothalamus</p></def></def-item></def-list></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>This study was conducted independently of any pharmaceutical organization or corporate sponsorship. The authors declare that they have no competing interests. RCP serves on the data monitoring committee for Pfizer Inc and Janssen Alzheimer Immunotherapy and is a consultant for Merck Inc, Roch Inc and Genentech Inc. NGR has received funding from Lilly Inc and for a TauRX Therapeutics multicenter study, and is a consultant for Cytox Ltd. BFB has received funding from GE Healthcare. DSK serves on the data safety monitoring board for Lundbeck Pharmaceuticals and for the Dominantly Inherited Alzheimer’s Disease Treatment Unit.</p></fn><fn><p><bold>Authors’ contributions</bold></p><p>TJF participated in the study conception, study design, acquisition of data, statistical analysis, data interpretation, manuscript preparation and coordination of the efforts related to the project. GES contributed to study design, subject recruitment, helped with statistical analysis and edited the manuscript. DWD and JP performed the neuropathologic assessment, provided critical feedback and edited the manuscript. NGR helped with subject recruitment, clinical assessment and edited the manuscript. SCL and MHS designed and ensured proper polysomnography methodology, oversaw the administration and scoring of the sleep studies and edited the manuscript. ZW, JAG, RU, DSK and RCP helped with subject recruitment, clinical assessment and edited the manuscript. BFB participated in study conception, subject recruitment, clinical assessment; designed and ensured proper sleep methodology and edited the manuscript. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We gratefully acknowledge support from the National Institutes of Health through grants R01AG15866, P50AG16574, U01AG06786 and P50NS072187 and also from The Mangurian Foundation for Lewy Body Dementia Research. We thank Jeremiah Aakre for his help with data management.</p></ack><ref-list id='Bib1'><title>References</title><ref id='CR1'><label>1.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ferman</surname><given-names>TJ</given-names></name><name><surname>Smith</surname><given-names>GE</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Ivnik</surname><given-names>RJ</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Knopman</surname><given-names>D</given-names></name><name><surname>Graff-Radford</surname><given-names>N</given-names></name><name><surname>Parisi</surname><given-names>J</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name></person-group><article-title>DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging</article-title><source>Neurology</source><year>2004</year><volume>62</volume><fpage>181</fpage><lpage>187</lpage><pub-id pub-id-type='doi'>10.1212/WNL.62.2.181</pub-id><pub-id pub-id-type='pmid'>14745051</pub-id></element-citation></ref><ref id='CR2'><label>2.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Rongve</surname><given-names>A</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Aarsland</surname><given-names>D</given-names></name></person-group><article-title>Frequency and correlates of caregiver reported sleep disturbances in a sample of persons with early dementia</article-title><source>J Am Geriatr Soc</source><year>2010</year><volume>58</volume><fpage>480</fpage><lpage>486</lpage><pub-id pub-id-type='doi'>10.1111/j.1532-5415.2010.02733.x</pub-id><pub-id pub-id-type='pmid'>20398116</pub-id></element-citation></ref><ref id='CR3'><label>3.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Boddy</surname><given-names>F</given-names></name><name><surname>Rowan</surname><given-names>EN</given-names></name><name><surname>Lett</surname><given-names>D</given-names></name><name><surname>O’Brien</surname><given-names>JT</given-names></name><name><surname>McKeith</surname><given-names>IG</given-names></name><name><surname>Burn</surname><given-names>DJ</given-names></name></person-group><article-title>Subjectively reported sleep quality and excessive daytime somnolence in Parkinson’s disease with and without dementia, dementia with Lewy bodies and Alzheimer’s disease</article-title><source>Int J Geriatr Psychiatry</source><year>2007</year><volume>22</volume><fpage>529</fpage><lpage>535</lpage><pub-id pub-id-type='doi'>10.1002/gps.1709</pub-id><pub-id pub-id-type='pmid'>17096456</pub-id></element-citation></ref><ref id='CR4'><label>4.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Lee</surname><given-names>DR</given-names></name><name><surname>McKeith</surname><given-names>I</given-names></name><name><surname>Mosimann</surname><given-names>U</given-names></name><collab>Ghosh‐Nodyal A, Thomas AJ</collab></person-group><article-title>Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms</article-title><source>Int J Geriatr Psychiatry</source><year>2013</year><volume>28</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type='doi'>10.1002/gps.3799</pub-id><pub-id pub-id-type='pmid'>22422615</pub-id></element-citation></ref><ref id='CR5'><label>5.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Bonanni</surname><given-names>E</given-names></name><name><surname>Maestri</surname><given-names>M</given-names></name><name><surname>Tognoni</surname><given-names>G</given-names></name><name><surname>Fabbrini</surname><given-names>M</given-names></name><name><surname>Nucciarone</surname><given-names>B</given-names></name><name><surname>Manca</surname><given-names>ML</given-names></name><name><surname>Gori</surname><given-names>S</given-names></name><name><surname>Iudice</surname><given-names>A</given-names></name><name><surname>Murri</surname><given-names>L</given-names></name></person-group><article-title>Daytime sleepiness in mild and moderate Alzheimer’s disease and its relationship with cognitive impairment</article-title><source>J Sleep Res</source><year>2005</year><volume>14</volume><fpage>311</fpage><lpage>317</lpage><pub-id pub-id-type='doi'>10.1111/j.1365-2869.2005.00462.x</pub-id><pub-id pub-id-type='pmid'>16120107</pub-id></element-citation></ref><ref id='CR6'><label>6.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Escandon</surname><given-names>A</given-names></name><name><surname>Al-Hammadi</surname><given-names>N</given-names></name><name><surname>Galvin</surname><given-names>JE</given-names></name></person-group><article-title>Effect of cognitive fluctuation on neuropsychological performance in aging and dementia</article-title><source>Neurology</source><year>2010</year><volume>74</volume><fpage>210</fpage><lpage>217</lpage><pub-id pub-id-type='doi'>10.1212/WNL.0b013e3181ca017d</pub-id><pub-id pub-id-type='pmid'>20083796</pub-id></element-citation></ref><ref id='CR7'><label>7.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ferman</surname><given-names>TJ</given-names></name><name><surname>Smith</surname><given-names>GE</given-names></name><name><surname>Kantarci</surname><given-names>K</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Pankratz</surname><given-names>VS</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Graff-Radford</surname><given-names>NR</given-names></name><name><surname>Wszolek</surname><given-names>Z</given-names></name><name><surname>Van Gerpen</surname><given-names>J</given-names></name><name><surname>Uitti</surname><given-names>R</given-names></name></person-group><article-title>Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies</article-title><source>Neurology</source><year>2013</year><volume>81</volume><fpage>2032</fpage><lpage>2038</lpage><pub-id pub-id-type='doi'>10.1212/01.wnl.0000436942.55281.47</pub-id><pub-id pub-id-type='pmid'>24212390</pub-id></element-citation></ref><ref id='CR8'><label>8.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Dijk</surname><given-names>DJ</given-names></name><name><surname>Groeger</surname><given-names>JA</given-names></name><name><surname>Stanley</surname><given-names>N</given-names></name><name><surname>Deacon</surname><given-names>S</given-names></name></person-group><article-title>Age-related reduction in daytime sleep propensity and nocturnal slow wave sleep</article-title><source>Sleep</source><year>2010</year><volume>33</volume><fpage>211</fpage><lpage>223</lpage><pub-id pub-id-type='pmid'>20175405</pub-id></element-citation></ref><ref id='CR9'><label>9.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Pao</surname><given-names>WC</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Ferman</surname><given-names>TJ</given-names></name><name><surname>Lin</surname><given-names>S-C</given-names></name><name><surname>Smith</surname><given-names>GE</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Graff-Radford</surname><given-names>NR</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Parisi</surname><given-names>JE</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name></person-group><article-title>Polysomnographic findings in dementia with Lewy bodies</article-title><source>Neurologist</source><year>2013</year><volume>19</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type='doi'>10.1097/NRL.0b013e31827c6bdd</pub-id><pub-id pub-id-type='pmid'>23269098</pub-id></element-citation></ref><ref id='CR10'><label>10.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Terzaghi</surname><given-names>M</given-names></name><name><surname>Arnaldi</surname><given-names>D</given-names></name><name><surname>Rizzetti</surname><given-names>MC</given-names></name><name><surname>Minafra</surname><given-names>B</given-names></name><name><surname>Cremascoli</surname><given-names>R</given-names></name><name><surname>Rustioni</surname><given-names>V</given-names></name><name><surname>Zangaglia</surname><given-names>R</given-names></name><name><surname>Pasotti</surname><given-names>C</given-names></name><name><surname>Sinforiani</surname><given-names>E</given-names></name><name><surname>Pacchetti</surname><given-names>C</given-names></name></person-group><article-title>Analysis of video‐polysomnographic sleep findings in dementia with Lewy bodies</article-title><source>Mov Disord</source><year>2013</year><volume>28</volume><fpage>1416</fpage><lpage>1423</lpage><pub-id pub-id-type='pmid'>23744574</pub-id></element-citation></ref><ref id='CR11'><label>11.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Trotti</surname><given-names>LM</given-names></name><name><surname>Bliwise</surname><given-names>DL</given-names></name></person-group><article-title>No increased risk of obstructive sleep apnea in Parkinson’s disease</article-title><source>Mov Disord</source><year>2010</year><volume>25</volume><fpage>2246</fpage><lpage>2249</lpage><pub-id pub-id-type='doi'>10.1002/mds.23231</pub-id><pub-id pub-id-type='pmid'>20669289</pub-id></element-citation></ref><ref id='CR12'><label>12.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Bliwise</surname><given-names>DL</given-names></name><name><surname>Trotti</surname><given-names>LM</given-names></name><name><surname>Yesavage</surname><given-names>JA</given-names></name><name><surname>Rye</surname><given-names>DB</given-names></name></person-group><article-title>Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer’s disease</article-title><source>Eur J Neurol</source><year>2012</year><volume>19</volume><fpage>918</fpage><lpage>923</lpage><pub-id pub-id-type='doi'>10.1111/j.1468-1331.2012.03673.x</pub-id><pub-id pub-id-type='pmid'>22340757</pub-id></element-citation></ref><ref id='CR13'><label>13.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>McKeith</surname><given-names>IG</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Lowe</surname><given-names>J</given-names></name><name><surname>Emre</surname><given-names>M</given-names></name><name><surname>O’Brien</surname><given-names>JT</given-names></name><name><surname>Feldman</surname><given-names>H</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>Duda</surname><given-names>JE</given-names></name><name><surname>Lippa</surname><given-names>C</given-names></name><name><surname>Perry</surname><given-names>EK</given-names></name><name><surname>Aarsland</surname><given-names>D</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><name><surname>Ballard</surname><given-names>CG</given-names></name><name><surname>Boeve</surname><given-names>B</given-names></name><name><surname>Burn</surname><given-names>DJ</given-names></name><name><surname>Costa</surname><given-names>D</given-names></name><name><surname>Del Ser</surname><given-names>T</given-names></name><name><surname>Dubois</surname><given-names>B</given-names></name><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Gauthier</surname><given-names>S</given-names></name><name><surname>Goetz</surname><given-names>CG</given-names></name><name><surname>Gomez-Tortosa</surname><given-names>E</given-names></name><name><surname>Halliday</surname><given-names>G</given-names></name><name><surname>Hansen</surname><given-names>LA</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Iwatsubo</surname><given-names>T</given-names></name><name><surname>Kalaria</surname><given-names>RN</given-names></name><name><surname>Kaufer</surname><given-names>D</given-names></name><name><surname>Kenny</surname><given-names>RA</given-names></name><name><surname>Korczyn</surname><given-names>A</given-names></name></person-group><article-title>Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>1863</fpage><lpage>1872</lpage><pub-id pub-id-type='doi'>10.1212/01.wnl.0000187889.17253.b1</pub-id><pub-id pub-id-type='pmid'>16237129</pub-id></element-citation></ref><ref id='CR14'><label>14.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Morris</surname><given-names>J</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name><name><surname>Froelich</surname><given-names>L</given-names></name><name><surname>Nordberg</surname><given-names>A</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Waldemar</surname><given-names>G</given-names></name><name><surname>Wahlund</surname><given-names>LO</given-names></name><name><surname>Dubois</surname><given-names>B</given-names></name></person-group><article-title>Harmonized diagnostic criteria for Alzheimer’s disease: recommendations</article-title><source>J Intern Med</source><year>2014</year><volume>275</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type='doi'>10.1111/joim.12199</pub-id><pub-id pub-id-type='pmid'>24605805</pub-id></element-citation></ref><ref id='CR15'><label>15.</label><element-citation publication-type='book'><person-group person-group-type='author'><collab>American Psychiatric Association</collab></person-group><source>Diagnostic and Statistical Manual of Mental Disorders</source><year>1994</year><edition>4</edition><publisher-loc>Washington, DC</publisher-loc><publisher-name>American Psychiatric Association</publisher-name></element-citation></ref><ref id='CR16'><label>16.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Reisberg</surname><given-names>B</given-names></name><name><surname>Ferris</surname><given-names>SH</given-names></name><name><surname>de Leon</surname><given-names>MJ</given-names></name><name><surname>Crook</surname><given-names>T</given-names></name></person-group><article-title>Global Deterioration Scale (GDS)</article-title><source>Psychopharmacol Bull</source><year>1988</year><volume>24</volume><fpage>661</fpage><lpage>663</lpage><pub-id pub-id-type='pmid'>3249768</pub-id></element-citation></ref><ref id='CR17'><label>17.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Folstein</surname><given-names>MF</given-names></name><name><surname>Folstein</surname><given-names>SE</given-names></name><name><surname>McHugh</surname><given-names>PR</given-names></name></person-group><article-title>“Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician</article-title><source>J Psychiatr Res</source><year>1975</year><volume>12</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type='doi'>10.1016/0022-3956(75)90026-6</pub-id><pub-id pub-id-type='pmid'>1202204</pub-id></element-citation></ref><ref id='CR18'><label>18.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Molano</surname><given-names>JR</given-names></name><name><surname>Ferman</surname><given-names>TJ</given-names></name><name><surname>Smith</surname><given-names>GE</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Bieniek</surname><given-names>K</given-names></name><name><surname>Haidar</surname><given-names>W</given-names></name><name><surname>Tippmann-Peikert</surname><given-names>M</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Graff-Radford</surname><given-names>NR</given-names></name></person-group><article-title>Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort</article-title><source>Sleep Med</source><year>2011</year><volume>12</volume><fpage>445</fpage><lpage>453</lpage><pub-id pub-id-type='doi'>10.1016/j.sleep.2010.12.009</pub-id><pub-id pub-id-type='pmid'>21349763</pub-id></element-citation></ref><ref id='CR19'><label>19.</label><element-citation publication-type='book'><person-group person-group-type='author'><name><surname>Fahn</surname><given-names>S</given-names></name><name><surname>Elton</surname><given-names>RL</given-names></name><collab>the UPDRS Development Committee</collab></person-group><person-group person-group-type='editor'><name><surname>Fahn</surname><given-names>S</given-names></name><name><surname>Marsden</surname><given-names>CD</given-names></name><name><surname>Calne</surname><given-names>DB</given-names></name><name><surname>Goldstein</surname><given-names>M</given-names></name></person-group><article-title>Unified Parkinson’s Disease Rating Scale</article-title><source>Recent Developments in Parkinson’s Disease</source><year>1987</year><publisher-loc>Florham Park, NJ</publisher-loc><publisher-name>Macmillan Healthcare Information</publisher-name><fpage>153</fpage><lpage>163</lpage></element-citation></ref><ref id='CR20'><label>20.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Johns</surname><given-names>MW</given-names></name></person-group><article-title>A new method for measuring daytime sleepiness: the Epworth sleepiness scale</article-title><source>Sleep</source><year>1991</year><volume>14</volume><fpage>540</fpage><lpage>545</lpage><pub-id pub-id-type='pmid'>1798888</pub-id></element-citation></ref><ref id='CR21'><label>21.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Lesher</surname><given-names>EL</given-names></name><name><surname>Berryhill</surname><given-names>JS</given-names></name></person-group><article-title>Validation of the Geriatric Depression Scale–Short Form among inpatients</article-title><source>J Clin Psychol</source><year>1994</year><volume>50</volume><fpage>256</fpage><lpage>260</lpage><pub-id pub-id-type='doi'>10.1002/1097-4679(199403)50:2&lt;256::AID-JCLP2270500218&gt;3.0.CO;2-E</pub-id><pub-id pub-id-type='pmid'>8014251</pub-id></element-citation></ref><ref id='CR22'><label>22.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Kaufer</surname><given-names>DI</given-names></name><name><surname>Cummings</surname><given-names>JL</given-names></name><name><surname>Ketchel</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>V</given-names></name><name><surname>MacMillan</surname><given-names>A</given-names></name><name><surname>Shelley</surname><given-names>T</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>DeKosky</surname><given-names>ST</given-names></name></person-group><article-title>Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory</article-title><source>J Neuropsychiatry Clin Neurosci</source><year>2000</year><volume>12</volume><fpage>233</fpage><lpage>239</lpage><pub-id pub-id-type='doi'>10.1176/appi.neuropsych.12.2.233</pub-id><pub-id pub-id-type='pmid'>11001602</pub-id></element-citation></ref><ref id='CR23'><label>23.</label><element-citation publication-type='journal'><person-group person-group-type='author'><collab>American Academy of Sleep Medicine Task Force</collab></person-group><article-title>Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research</article-title><source>Sleep</source><year>1999</year><volume>22</volume><fpage>667</fpage><lpage>689</lpage><pub-id pub-id-type='pmid'>10450601</pub-id></element-citation></ref><ref id='CR24'><label>24.</label><element-citation publication-type='book'><person-group person-group-type='author'><name><surname>Iber</surname><given-names>C</given-names></name><name><surname>Ancoli-Israel</surname><given-names>S</given-names></name><name><surname>Chesson</surname><given-names>A</given-names></name><name><surname>Quan</surname><given-names>SF</given-names></name><collab>for the American Academy of Sleep Medicine</collab></person-group><source>The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications</source><year>2007</year><edition>1</edition><publisher-loc>Westchester, IL</publisher-loc><publisher-name>American Academy of Sleep Medicine</publisher-name></element-citation></ref><ref id='CR25'><label>25.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Duda</surname><given-names>JE</given-names></name><name><surname>Duyckaerts</surname><given-names>C</given-names></name><name><surname>Gasser</surname><given-names>T</given-names></name><name><surname>Halliday</surname><given-names>GM</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Leverenz</surname><given-names>JB</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name><name><surname>Wszolek</surname><given-names>ZK</given-names></name><name><surname>Litvan</surname><given-names>I</given-names></name></person-group><article-title>Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria</article-title><source>Lancet Neurol</source><year>2009</year><volume>8</volume><fpage>1150</fpage><lpage>1157</lpage><pub-id pub-id-type='doi'>10.1016/S1474-4422(09)70238-8</pub-id><pub-id pub-id-type='pmid'>19909913</pub-id></element-citation></ref><ref id='CR26'><label>26.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>Neuropathological stageing of Alzheimer-related changes</article-title><source>Acta Neuropathol</source><year>1991</year><volume>82</volume><fpage>239</fpage><lpage>259</lpage><pub-id pub-id-type='doi'>10.1007/BF00308809</pub-id><pub-id pub-id-type='pmid'>1759558</pub-id></element-citation></ref><ref id='CR27'><label>27.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Unruh</surname><given-names>ML</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>An</surname><given-names>MW</given-names></name><name><surname>Buysse</surname><given-names>DJ</given-names></name><name><surname>Nieto</surname><given-names>FJ</given-names></name><name><surname>Yeh</surname><given-names>JL</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name></person-group><article-title>Subjective and objective sleep quality and aging in the sleep heart health study</article-title><source>J Am Geriatr Soc</source><year>2008</year><volume>56</volume><fpage>1218</fpage><lpage>1227</lpage><pub-id pub-id-type='doi'>10.1111/j.1532-5415.2008.01755.x</pub-id><pub-id pub-id-type='pmid'>18482295</pub-id></element-citation></ref><ref id='CR28'><label>28.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Bonnet</surname><given-names>MH</given-names></name><name><surname>Arand</surname><given-names>DL</given-names></name></person-group><article-title>Hyperarousal and insomnia: state of the science</article-title><source>Sleep Med Rev</source><year>2010</year><volume>14</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type='doi'>10.1016/j.smrv.2009.05.002</pub-id><pub-id pub-id-type='pmid'>19640748</pub-id></element-citation></ref><ref id='CR29'><label>29.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Roehrs</surname><given-names>TA</given-names></name><name><surname>Randall</surname><given-names>S</given-names></name><name><surname>Harris</surname><given-names>E</given-names></name><name><surname>Maan</surname><given-names>R</given-names></name><name><surname>Roth</surname><given-names>T</given-names></name></person-group><article-title>MSLT in primary insomnia: stability and relation to nocturnal sleep</article-title><source>Sleep</source><year>2011</year><volume>34</volume><fpage>1647</fpage><lpage>1652</lpage><pub-id pub-id-type='pmid'>22131601</pub-id></element-citation></ref><ref id='CR30'><label>30.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Pal</surname><given-names>P</given-names></name><name><surname>Calne</surname><given-names>S</given-names></name><name><surname>Samii</surname><given-names>A</given-names></name><name><surname>Fleming</surname><given-names>J</given-names></name></person-group><article-title>A review of normal sleep and its disturbances in Parkinson’s disease</article-title><source>Parkinsonism Relat Disord</source><year>1999</year><volume>5</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type='doi'>10.1016/S1353-8020(99)00011-5</pub-id><pub-id pub-id-type='pmid'>18591114</pub-id></element-citation></ref><ref id='CR31'><label>31.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Arnulf</surname><given-names>I</given-names></name><name><surname>Konofal</surname><given-names>E</given-names></name><name><surname>Merino-Andreu</surname><given-names>M</given-names></name><name><surname>Houeto</surname><given-names>J</given-names></name><name><surname>Mesnage</surname><given-names>V</given-names></name><name><surname>Welter</surname><given-names>M</given-names></name><name><surname>Lacomblez</surname><given-names>L</given-names></name><name><surname>Golmard</surname><given-names>J</given-names></name><name><surname>Derenne</surname><given-names>J</given-names></name><name><surname>Agid</surname><given-names>Y</given-names></name></person-group><article-title>Parkinson’s disease and sleepiness: An integral part of PD</article-title><source>Neurology</source><year>2002</year><volume>58</volume><fpage>1019</fpage><lpage>1024</lpage><pub-id pub-id-type='doi'>10.1212/WNL.58.7.1019</pub-id><pub-id pub-id-type='pmid'>11940685</pub-id></element-citation></ref><ref id='CR32'><label>32.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Rye</surname><given-names>DB</given-names></name><name><surname>Bliwise</surname><given-names>DL</given-names></name><name><surname>Dihenia</surname><given-names>B</given-names></name><name><surname>Gurecki</surname><given-names>P</given-names></name></person-group><article-title>Daytime sleepiness in Parkinson’s disease</article-title><source>J Sleep Res</source><year>2000</year><volume>9</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type='doi'>10.1046/j.1365-2869.2000.00201.x</pub-id><pub-id pub-id-type='pmid'>10733691</pub-id></element-citation></ref><ref id='CR33'><label>33.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Shpirer</surname><given-names>I</given-names></name><name><surname>Miniovitz</surname><given-names>A</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Goldstein</surname><given-names>R</given-names></name><name><surname>Prokhorov</surname><given-names>T</given-names></name><name><surname>Theitler</surname><given-names>J</given-names></name><name><surname>Pollak</surname><given-names>L</given-names></name><name><surname>Rabey</surname><given-names>JM</given-names></name></person-group><article-title>Excessive daytime sleepiness in patients with Parkinson’s disease: a polysomnography study</article-title><source>Mov Disord</source><year>2006</year><volume>21</volume><fpage>1432</fpage><lpage>1438</lpage><pub-id pub-id-type='doi'>10.1002/mds.21002</pub-id><pub-id pub-id-type='pmid'>16773617</pub-id></element-citation></ref><ref id='CR34'><label>34.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Peeraully</surname><given-names>T</given-names></name><name><surname>Yong</surname><given-names>MH</given-names></name><name><surname>Chokroverty</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>EK</given-names></name></person-group><article-title>Sleep and Parkinson’s disease: a review of case‐control polysomnography studies</article-title><source>Mov Disord</source><year>2012</year><volume>27</volume><fpage>1729</fpage><lpage>1737</lpage><pub-id pub-id-type='doi'>10.1002/mds.25197</pub-id><pub-id pub-id-type='pmid'>23115083</pub-id></element-citation></ref><ref id='CR35'><label>35.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Emre</surname><given-names>M</given-names></name><name><surname>Aarsland</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>R</given-names></name><name><surname>Burn</surname><given-names>DJ</given-names></name><name><surname>Duyckaerts</surname><given-names>C</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Broe</surname><given-names>GA</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Gauthier</surname><given-names>S</given-names></name><name><surname>Goldman</surname><given-names>J</given-names></name><name><surname>Goetz</surname><given-names>C</given-names></name><name><surname>Korczyn</surname><given-names>A</given-names></name><name><surname>Lees</surname><given-names>A</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Litvan</surname><given-names>I</given-names></name><name><surname>McKeith</surname><given-names>I</given-names></name><name><surname>Olanow</surname><given-names>W</given-names></name><name><surname>Poewe</surname><given-names>W</given-names></name><name><surname>Quinn</surname><given-names>N</given-names></name><name><surname>Sampaio</surname><given-names>C</given-names></name><name><surname>Tolosa</surname><given-names>E</given-names></name><name><surname>Dubois</surname><given-names>B</given-names></name></person-group><article-title>Clinical diagnostic criteria for dementia associated with Parkinson’s disease</article-title><source>Mov Disord</source><year>2007</year><volume>22</volume><fpage>1689</fpage><lpage>1707</lpage><pub-id pub-id-type='doi'>10.1002/mds.21507</pub-id><pub-id pub-id-type='pmid'>17542011</pub-id></element-citation></ref><ref id='CR36'><label>36.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ondo</surname><given-names>WG</given-names></name><name><surname>Dat Vuong</surname><given-names>K</given-names></name><name><surname>Khan</surname><given-names>H</given-names></name><name><surname>Atassi</surname><given-names>F</given-names></name><name><surname>Kwak</surname><given-names>C</given-names></name><name><surname>Jankovic</surname><given-names>J</given-names></name></person-group><article-title>Daytime sleepiness and other sleep disorders in Parkinson’s disease</article-title><source>Neurology</source><year>2001</year><volume>57</volume><fpage>1392</fpage><lpage>1396</lpage><pub-id pub-id-type='doi'>10.1212/WNL.57.8.1392</pub-id><pub-id pub-id-type='pmid'>11673578</pub-id></element-citation></ref><ref id='CR37'><label>37.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Johansson</surname><given-names>P</given-names></name><name><surname>Alehagen</surname><given-names>U</given-names></name><name><surname>Svanborg</surname><given-names>E</given-names></name><name><surname>Dahlström</surname><given-names>U</given-names></name><name><surname>Broström</surname><given-names>A</given-names></name></person-group><article-title>Sleep disordered breathing in an elderly community-living population: relationship to cardiac function, insomnia symptoms and daytime sleepiness</article-title><source>Sleep Med</source><year>2009</year><volume>10</volume><fpage>1005</fpage><lpage>1011</lpage><pub-id pub-id-type='doi'>10.1016/j.sleep.2009.01.011</pub-id><pub-id pub-id-type='pmid'>19464948</pub-id></element-citation></ref><ref id='CR38'><label>38.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ancoli-Israel</surname><given-names>S</given-names></name><name><surname>Kripke</surname><given-names>DF</given-names></name><name><surname>Klauber</surname><given-names>MR</given-names></name><name><surname>Mason</surname><given-names>WJ</given-names></name><name><surname>Fell</surname><given-names>R</given-names></name><name><surname>Kaplan</surname><given-names>O</given-names></name></person-group><article-title>Sleep-disordered breathing in community-dwelling elderly</article-title><source>Sleep</source><year>1991</year><volume>14</volume><fpage>486</fpage><lpage>495</lpage><pub-id pub-id-type='pmid'>1798880</pub-id></element-citation></ref><ref id='CR39'><label>39.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ancoli-Israel</surname><given-names>S</given-names></name><name><surname>Kripke</surname><given-names>D</given-names></name><name><surname>Klauber</surname><given-names>M</given-names></name><name><surname>Mason</surname><given-names>W</given-names></name><name><surname>Fell</surname><given-names>R</given-names></name><name><surname>Kaplan</surname><given-names>O</given-names></name></person-group><article-title>Periodic limb movements in sleep in community-dwelling elderly</article-title><source>Sleep</source><year>1991</year><volume>14</volume><fpage>496</fpage><lpage>500</lpage><pub-id pub-id-type='pmid'>1798881</pub-id></element-citation></ref><ref id='CR40'><label>40.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Franco</surname><given-names>JG</given-names></name><name><surname>Trzepacz</surname><given-names>PT</given-names></name><name><surname>Meagher</surname><given-names>DJ</given-names></name><name><surname>Kean</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>JL</given-names></name><name><surname>Kishi</surname><given-names>Y</given-names></name><name><surname>Furlanetto</surname><given-names>LM</given-names></name><name><surname>Negreiros</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>MC</given-names></name></person-group><article-title>Three core domains of delirium validated using exploratory and confirmatory factor analyses</article-title><source>Psychosomatics</source><year>2013</year><volume>54</volume><fpage>227</fpage><lpage>238</lpage><pub-id pub-id-type='doi'>10.1016/j.psym.2012.06.010</pub-id><pub-id pub-id-type='pmid'>23218057</pub-id></element-citation></ref><ref id='CR41'><label>41.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Inouye</surname><given-names>SK</given-names></name><name><surname>van Dyck</surname><given-names>CH</given-names></name><name><surname>Alessi</surname><given-names>CA</given-names></name><name><surname>Balkin</surname><given-names>S</given-names></name><name><surname>Siegal</surname><given-names>AP</given-names></name><name><surname>Horwitz</surname><given-names>RI</given-names></name></person-group><article-title>Clarifying confusion: the confusion assessment method: a new method for detection of delirium</article-title><source>Ann Intern Med</source><year>1990</year><volume>113</volume><fpage>941</fpage><lpage>948</lpage><pub-id pub-id-type='doi'>10.7326/0003-4819-113-12-941</pub-id><pub-id pub-id-type='pmid'>2240918</pub-id></element-citation></ref><ref id='CR42'><label>42.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Lee</surname><given-names>DR</given-names></name><name><surname>McKeith</surname><given-names>I</given-names></name><name><surname>Mosimann</surname><given-names>U</given-names></name><name><surname>Ghosh-Nodial</surname><given-names>A</given-names></name><name><surname>Grayson</surname><given-names>L</given-names></name><name><surname>Wilson</surname><given-names>B</given-names></name><name><surname>Thomas</surname><given-names>AJ</given-names></name></person-group><article-title>The Dementia Cognitive Fluctuation Scale, a new psychometric test for clinicians to identify cognitive fluctuations in people with dementia</article-title><source>Am J Geriatr Psychiatry</source><year>2013</year><volume>22</volume><fpage>926</fpage><lpage>935</lpage><pub-id pub-id-type='doi'>10.1016/j.jagp.2013.01.072</pub-id><pub-id pub-id-type='pmid'>24332982</pub-id></element-citation></ref><ref id='CR43'><label>43.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ballard</surname><given-names>C</given-names></name><name><surname>O’Brien</surname><given-names>J</given-names></name><name><surname>Gray</surname><given-names>A</given-names></name><name><surname>Cormack</surname><given-names>F</given-names></name><name><surname>Ayre</surname><given-names>G</given-names></name><name><surname>Rowan</surname><given-names>E</given-names></name><name><surname>Thompson</surname><given-names>P</given-names></name><name><surname>Bucks</surname><given-names>R</given-names></name><name><surname>McKeith</surname><given-names>I</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name></person-group><article-title>Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease</article-title><source>Arch Neurol</source><year>2001</year><volume>58</volume><fpage>977</fpage><lpage>982</lpage><pub-id pub-id-type='doi'>10.1001/archneur.58.6.977</pub-id><pub-id pub-id-type='pmid'>11405813</pub-id></element-citation></ref><ref id='CR44'><label>44.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Walker</surname><given-names>MP</given-names></name><name><surname>Ayre</surname><given-names>GA</given-names></name><name><surname>Cummings</surname><given-names>JL</given-names></name><name><surname>Wesnes</surname><given-names>K</given-names></name><name><surname>McKeith</surname><given-names>IG</given-names></name><name><surname>O’Brien</surname><given-names>JT</given-names></name><name><surname>Ballard</surname><given-names>CG</given-names></name></person-group><article-title>The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale: two methods to assess fluctuating confusion in dementia</article-title><source>Br J Psychiatry</source><year>2000</year><volume>177</volume><fpage>252</fpage><lpage>256</lpage><pub-id pub-id-type='doi'>10.1192/bjp.177.3.252</pub-id><pub-id pub-id-type='pmid'>11040887</pub-id></element-citation></ref><ref id='CR45'><label>45.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Bliwise</surname><given-names>DL</given-names></name><name><surname>Scullin</surname><given-names>MK</given-names></name><name><surname>Trotti</surname><given-names>LM</given-names></name></person-group><article-title>Fluctuations in cognition and alertness vary independently in dementia with Lewy bodies</article-title><source>Mov Disord</source><year>2014</year><volume>29</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type='doi'>10.1002/mds.25707</pub-id><pub-id pub-id-type='pmid'>24151106</pub-id></element-citation></ref><ref id='CR46'><label>46.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Ghebremedhin</surname><given-names>E</given-names></name><name><surname>Rub</surname><given-names>U</given-names></name><name><surname>Bratzke</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>Stages in the development of Parkinson’s disease-related pathology</article-title><source>Cell Tissue Res</source><year>2004</year><volume>318</volume><fpage>121</fpage><lpage>134</lpage><pub-id pub-id-type='doi'>10.1007/s00441-004-0956-9</pub-id><pub-id pub-id-type='pmid'>15338272</pub-id></element-citation></ref><ref id='CR47'><label>47.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name><name><surname>Rüb</surname><given-names>U</given-names></name><name><surname>de Vos</surname><given-names>RA</given-names></name><name><surname>Jansen Steur</surname><given-names>EN</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>Staging of brain pathology related to sporadic Parkinson’s disease</article-title><source>Neurobiol Aging</source><year>2003</year><volume>24</volume><fpage>197</fpage><lpage>211</lpage><pub-id pub-id-type='doi'>10.1016/S0197-4580(02)00065-9</pub-id><pub-id pub-id-type='pmid'>12498954</pub-id></element-citation></ref><ref id='CR48'><label>48.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Moruzzi</surname><given-names>G</given-names></name><name><surname>Magoun</surname><given-names>HW</given-names></name></person-group><article-title>Brain stem reticular formation and activation of the EEG</article-title><source>Electroencephalogr Clin Neurophysiol</source><year>1949</year><volume>1</volume><fpage>455</fpage><lpage>473</lpage><pub-id pub-id-type='doi'>10.1016/0013-4694(49)90219-9</pub-id><pub-id pub-id-type='pmid'>18421835</pub-id></element-citation></ref><ref id='CR49'><label>49.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Buzsáki</surname><given-names>G</given-names></name><name><surname>Bickford</surname><given-names>RG</given-names></name><name><surname>Ponomareff</surname><given-names>G</given-names></name><name><surname>Thal</surname><given-names>L</given-names></name><name><surname>Mandel</surname><given-names>R</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><article-title>Nucleus basalis and thalamic control of neocortical activity in the freely moving rat</article-title><source>J Neurosci</source><year>1988</year><volume>8</volume><fpage>4007</fpage><lpage>4026</lpage><pub-id pub-id-type='pmid'>3183710</pub-id></element-citation></ref><ref id='CR50'><label>50.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Saper</surname><given-names>CB</given-names></name><name><surname>Scammell</surname><given-names>TE</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name></person-group><article-title>Hypothalamic regulation of sleep and circadian rhythms</article-title><source>Nature</source><year>2005</year><volume>437</volume><fpage>1257</fpage><lpage>1263</lpage><pub-id pub-id-type='doi'>10.1038/nature04284</pub-id><pub-id pub-id-type='pmid'>16251950</pub-id></element-citation></ref><ref id='CR51'><label>51.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Aston-Jones</surname><given-names>G</given-names></name><name><surname>Bloom</surname><given-names>FE</given-names></name></person-group><article-title>Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle</article-title><source>J Neurosci</source><year>1981</year><volume>1</volume><fpage>876</fpage><lpage>886</lpage><pub-id pub-id-type='pmid'>7346592</pub-id></element-citation></ref><ref id='CR52'><label>52.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Panula</surname><given-names>P</given-names></name><name><surname>Nuutinen</surname><given-names>S</given-names></name></person-group><article-title>The histaminergic network in the brain: basic organization and role in disease</article-title><source>Nat Rev Neurosci</source><year>2013</year><volume>14</volume><fpage>472</fpage><lpage>487</lpage><pub-id pub-id-type='doi'>10.1038/nrn3526</pub-id><pub-id pub-id-type='pmid'>23783198</pub-id></element-citation></ref><ref id='CR53'><label>53.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Saper</surname><given-names>CB</given-names></name><name><surname>Fuller</surname><given-names>PM</given-names></name><name><surname>Pedersen</surname><given-names>NP</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Scammell</surname><given-names>TE</given-names></name></person-group><article-title>Sleep state switching</article-title><source>Neuron</source><year>2010</year><volume>68</volume><fpage>1023</fpage><lpage>1042</lpage><pub-id pub-id-type='doi'>10.1016/j.neuron.2010.11.032</pub-id><pub-id pub-id-type='pmid'>21172606</pub-id></element-citation></ref><ref id='CR54'><label>54.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Lee</surname><given-names>MG</given-names></name><name><surname>Hassani</surname><given-names>OK</given-names></name><name><surname>Jones</surname><given-names>BE</given-names></name></person-group><article-title>Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle</article-title><source>J Neurosci</source><year>2005</year><volume>25</volume><fpage>6716</fpage><lpage>6720</lpage><pub-id pub-id-type='doi'>10.1523/JNEUROSCI.1887-05.2005</pub-id><pub-id pub-id-type='pmid'>16014733</pub-id></element-citation></ref><ref id='CR55'><label>55.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Saper</surname><given-names>CB</given-names></name></person-group><article-title>The neurobiology of sleep</article-title><source>Continuum (Minneap Minn)</source><year>2013</year><volume>19</volume><fpage>19</fpage><lpage>31</lpage><pub-id pub-id-type='pmid'>23385692</pub-id></element-citation></ref><ref id='CR56'><label>56.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Drouot</surname><given-names>X</given-names></name><name><surname>Moutereau</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>J</given-names></name><name><surname>Lefaucheur</surname><given-names>J</given-names></name><name><surname>Creange</surname><given-names>A</given-names></name><name><surname>Remy</surname><given-names>P</given-names></name><name><surname>Goldenberg</surname><given-names>F</given-names></name><name><surname>d’Ortho</surname><given-names>M</given-names></name></person-group><article-title>Low levels of ventricular CSF orexin/hypocretin in advanced PD</article-title><source>Neurology</source><year>2003</year><volume>61</volume><fpage>540</fpage><lpage>543</lpage><pub-id pub-id-type='doi'>10.1212/01.WNL.0000078194.53210.48</pub-id><pub-id pub-id-type='pmid'>12939433</pub-id></element-citation></ref><ref id='CR57'><label>57.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Fronczek</surname><given-names>R</given-names></name><name><surname>Overeem</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Hegeman</surname><given-names>IM</given-names></name><name><surname>van Pelt</surname><given-names>J</given-names></name><name><surname>van Duinen</surname><given-names>SG</given-names></name><name><surname>Lammers</surname><given-names>GJ</given-names></name><name><surname>Swaab</surname><given-names>DF</given-names></name></person-group><article-title>Hypocretin (orexin) loss in Parkinson’s disease</article-title><source>Brain</source><year>2007</year><volume>130</volume><fpage>1577</fpage><lpage>1585</lpage><pub-id pub-id-type='doi'>10.1093/brain/awm090</pub-id><pub-id pub-id-type='pmid'>17470494</pub-id></element-citation></ref><ref id='CR58'><label>58.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Compta</surname><given-names>Y</given-names></name><name><surname>Santamaria</surname><given-names>J</given-names></name><name><surname>Ratti</surname><given-names>L</given-names></name><name><surname>Tolosa</surname><given-names>E</given-names></name><name><surname>Iranzo</surname><given-names>A</given-names></name><name><surname>Muñoz</surname><given-names>E</given-names></name><name><surname>Valldeoriola</surname><given-names>F</given-names></name><name><surname>Casamitjana</surname><given-names>R</given-names></name><name><surname>Ríos</surname><given-names>J</given-names></name><name><surname>Marti</surname><given-names>MJ</given-names></name></person-group><article-title>Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson’s disease dementia</article-title><source>Brain</source><year>2009</year><volume>132</volume><fpage>3308</fpage><lpage>3317</lpage><pub-id pub-id-type='doi'>10.1093/brain/awp263</pub-id><pub-id pub-id-type='pmid'>19858078</pub-id></element-citation></ref><ref id='CR59'><label>59.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Kasanuki</surname><given-names>K</given-names></name><name><surname>Iseki</surname><given-names>E</given-names></name><name><surname>Kondo</surname><given-names>D</given-names></name><name><surname>Fujishiro</surname><given-names>H</given-names></name><name><surname>Minegishi</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Katsuse</surname><given-names>O</given-names></name><name><surname>Hino</surname><given-names>H</given-names></name><name><surname>Kosaka</surname><given-names>K</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name></person-group><article-title>Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies</article-title><source>Neurosci Lett</source><year>2014</year><volume>569</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type='doi'>10.1016/j.neulet.2014.03.020</pub-id><pub-id pub-id-type='pmid'>24704327</pub-id></element-citation></ref><ref id='CR60'><label>60.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Lessig</surname><given-names>S</given-names></name><name><surname>Ubhi</surname><given-names>K</given-names></name><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Adame</surname><given-names>A</given-names></name><name><surname>Pham</surname><given-names>E</given-names></name><name><surname>Remidios</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Hansen</surname><given-names>LA</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name></person-group><article-title>Reduced hypocretin (orexin) levels in dementia with Lewy bodies</article-title><source>Neuroreport</source><year>2010</year><volume>21</volume><fpage>756</fpage><lpage>760</lpage><pub-id pub-id-type='doi'>10.1097/WNR.0b013e32833bfb7c</pub-id><pub-id pub-id-type='pmid'>20531237</pub-id></element-citation></ref><ref id='CR61'><label>61.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Claassen</surname><given-names>DO</given-names></name><name><surname>Josephs</surname><given-names>KA</given-names></name><name><surname>Ahlskog</surname><given-names>JE</given-names></name><name><surname>Silber</surname><given-names>MH</given-names></name><name><surname>Tippmann-Peikert</surname><given-names>M</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name></person-group><article-title>REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century</article-title><source>Neurology</source><year>2010</year><volume>75</volume><fpage>494</fpage><lpage>499</lpage><pub-id pub-id-type='doi'>10.1212/WNL.0b013e3181ec7fac</pub-id><pub-id pub-id-type='pmid'>20668263</pub-id></element-citation></ref><ref id='CR62'><label>62.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Iber</surname><given-names>C</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Gilpin</surname><given-names>AK</given-names></name><name><surname>Quan</surname><given-names>SF</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Gottlieb</surname><given-names>DJ</given-names></name><name><surname>Rapoport</surname><given-names>D</given-names></name><name><surname>Resnick</surname><given-names>HE</given-names></name><name><surname>Sanders</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name></person-group><article-title>Polysomnography performed in the unattended home versus the attended laboratory setting-Sleep Heart Health Study methodology</article-title><source>Sleep</source><year>2004</year><volume>27</volume><fpage>536</fpage><lpage>540</lpage><pub-id pub-id-type='pmid'>15164911</pub-id></element-citation></ref><ref id='CR63'><label>63.</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Bruyneel</surname><given-names>M</given-names></name><name><surname>Sanida</surname><given-names>C</given-names></name><name><surname>Art</surname><given-names>G</given-names></name><name><surname>Libert</surname><given-names>W</given-names></name><name><surname>Cuvelier</surname><given-names>L</given-names></name><name><surname>Paesmans</surname><given-names>M</given-names></name><name><surname>Sergysels</surname><given-names>R</given-names></name><name><surname>Ninane</surname><given-names>V</given-names></name></person-group><article-title>Sleep efficiency during sleep studies: results of a prospective study comparing home‐based and in‐hospital polysomnography</article-title><source>J Sleep Res</source><year>2011</year><volume>20</volume><fpage>201</fpage><lpage>206</lpage><pub-id pub-id-type='doi'>10.1111/j.1365-2869.2010.00859.x</pub-id><pub-id pub-id-type='pmid'>20561176</pub-id></element-citation></ref></ref-list></back></article></PAPER>